Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.88 SAR | -0.16% | -0.92% | -17.33% |
Nov. 29 | Goldman Sachs Lifts Jarir Marketing's PT, Affirms Buy Rating | MT |
Nov. 13 | AlphaMena Trims Jarir Marketing's PT, Affirms Add Rating | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 18.55 | 17.2 | 15.55 | 15.06 | 15.46 | |||||
Return on Total Capital | 28.3 | 26.14 | 25.57 | 25.55 | 25.83 | |||||
Return On Equity % | 58.89 | 59.52 | 56.77 | 54.32 | 54.46 | |||||
Return on Common Equity | 58.89 | 59.52 | 56.77 | 54.32 | 54.46 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 15.16 | 14.29 | 13.56 | 13.77 | 12.07 | |||||
SG&A Margin | 3.04 | 2.97 | 2.98 | 3.53 | 2.89 | |||||
EBITDA Margin % | 13.51 | 12.53 | 11.79 | 11.42 | 10.4 | |||||
EBITA Margin % | 12.71 | 11.83 | 11.1 | 10.74 | 9.77 | |||||
EBIT Margin % | 12.71 | 11.83 | 11.1 | 10.74 | 9.77 | |||||
Income From Continuing Operations Margin % | 11.69 | 10.78 | 10.91 | 10.33 | 9.18 | |||||
Net Income Margin % | 11.69 | 10.78 | 10.91 | 10.33 | 9.18 | |||||
Net Avail. For Common Margin % | 11.69 | 10.78 | 10.91 | 10.33 | 9.18 | |||||
Normalized Net Income Margin | 7.49 | 7.07 | 6.65 | 6.44 | 5.85 | |||||
Levered Free Cash Flow Margin | 6.57 | 10.27 | 11.07 | 6.36 | 2.68 | |||||
Unlevered Free Cash Flow Margin | 7.02 | 10.6 | 11.36 | 6.63 | 2.96 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.33 | 2.33 | 2.24 | 2.24 | 2.53 | |||||
Fixed Assets Turnover | 5.85 | 5.35 | 5.47 | 5.84 | 6.65 | |||||
Receivables Turnover (Average Receivables) | 39.13 | 47.22 | 49.25 | 44.5 | 44.27 | |||||
Inventory Turnover (Average Inventory) | 6.17 | 6.21 | 6.18 | 6.34 | 6.28 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.15 | 1.21 | 1.27 | 1.38 | 1.41 | |||||
Quick Ratio | 0.23 | 0.25 | 0.44 | 0.53 | 0.31 | |||||
Operating Cash Flow to Current Liabilities | 0.63 | 0.92 | 0.87 | 0.59 | 0.44 | |||||
Days Sales Outstanding (Average Receivables) | 9.33 | 7.75 | 7.41 | 8.2 | 8.24 | |||||
Days Outstanding Inventory (Average Inventory) | 59.18 | 58.91 | 59.07 | 57.55 | 58.13 | |||||
Average Days Payable Outstanding | 41.06 | 41.63 | 50.43 | 52.61 | 41.22 | |||||
Cash Conversion Cycle (Average Days) | 27.45 | 25.04 | 16.05 | 13.15 | 25.15 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 66.88 | 46.06 | 36.29 | 40.01 | 40.32 | |||||
Total Debt / Total Capital | 40.08 | 31.53 | 26.63 | 28.58 | 28.74 | |||||
LT Debt/Equity | 39.3 | 33.66 | 29.39 | 32.37 | 32.81 | |||||
Long-Term Debt / Total Capital | 23.55 | 23.05 | 21.56 | 23.12 | 23.38 | |||||
Total Liabilities / Total Assets | 58.89 | 56.86 | 56.98 | 57.69 | 56.9 | |||||
EBIT / Interest Expense | 17.51 | 22.71 | 23.83 | 24.74 | 21.9 | |||||
EBITDA / Interest Expense | 19.88 | 25.94 | 27.5 | 28.84 | 25.77 | |||||
(EBITDA - Capex) / Interest Expense | 18.5 | 24.3 | 25.85 | 27.6 | 24.86 | |||||
Total Debt / EBITDA | 0.9 | 0.63 | 0.55 | 0.61 | 0.59 | |||||
Net Debt / EBITDA | 0.88 | 0.55 | 0.18 | 0.17 | 0.55 | |||||
Total Debt / (EBITDA - Capex) | 0.97 | 0.67 | 0.59 | 0.64 | 0.61 | |||||
Net Debt / (EBITDA - Capex) | 0.95 | 0.59 | 0.19 | 0.17 | 0.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 14.44 | 10.46 | -2.34 | 3.34 | 12.81 | |||||
Gross Profit, 1 Yr. Growth % | 5.64 | 4.08 | -7.31 | 4.91 | -1.1 | |||||
EBITDA, 1 Yr. Growth % | 9.95 | 3.03 | -6.77 | -0.16 | 1.75 | |||||
EBITA, 1 Yr. Growth % | 9.48 | 2.79 | -6.92 | -0.34 | 1.61 | |||||
EBIT, 1 Yr. Growth % | 9.48 | 2.79 | -6.92 | -0.34 | 1.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 2.58 | 1.85 | -1.11 | -2.23 | 0.34 | |||||
Net Income, 1 Yr. Growth % | 2.58 | 1.85 | -1.11 | -2.23 | 0.34 | |||||
Normalized Net Income, 1 Yr. Growth % | 3.65 | 4.22 | -6.65 | -0.19 | 1.45 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 2.58 | 1.85 | -1.11 | -2.23 | 0.34 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.29 | -20.71 | 11.75 | 16.71 | 10.57 | |||||
Inventory, 1 Yr. Growth % | 19.13 | 3.8 | -5.59 | 6.85 | 24.91 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 58.35 | -3.1 | -5.97 | -0.18 | -1.77 | |||||
Total Assets, 1 Yr. Growth % | 24.47 | -0.07 | 2.84 | 3.54 | -3.45 | |||||
Tangible Book Value, 1 Yr. Growth % | -3.2 | 4.87 | 2.54 | 1.84 | -1.66 | |||||
Common Equity, 1 Yr. Growth % | -3.2 | 4.87 | 2.54 | 1.84 | -1.66 | |||||
Cash From Operations, 1 Yr. Growth % | 39.79 | 43.58 | 2.21 | -30.05 | -31.02 | |||||
Capital Expenditures, 1 Yr. Growth % | -32.73 | -5.46 | -12.52 | -27.44 | -14.29 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 86.58 | 72.85 | 6.41 | -40.77 | -52.88 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 97.82 | 66.8 | 5.81 | -39.83 | -50.09 | |||||
Dividend Per Share, 1 Yr. Growth % | 1.91 | -1.88 | -4.46 | 6 | 5.03 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.16 | 12.43 | 3.86 | 0.46 | 7.97 | |||||
Gross Profit, 2 Yr. CAGR % | 6.42 | 4.86 | -1.78 | -1.39 | 1.86 | |||||
EBITDA, 2 Yr. CAGR % | 10.9 | 6.15 | -2.71 | -3.39 |